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raveling has always been a risky 
venture. In times gone by, the 
traveler left the security of home 
to face myriad dangers, including 
accidents, storms, infectious disease, 
malnutrition, and assault. Consider 
the choices faced by travelers from 
New York to San Francisco before the 
transcontinental railroad traversed 
North America in 1869. They had to 
choose between a harsh overland route 
by wagon train through forbidding 
territory, a sailing expedition around 
Cape Horn through some of the 
most treacherous waters on earth, or 
the most dangerous route, by sea to 
Panama, and then a trek by canoe, 
mule, and foot through mosquito-
infested jungles in the hope of booking 
passage by ship from the Paciﬁ  c side. 
By comparison, today’s traveler would 
seem to have little to worry about.
    Risks of Modern Travel
    But travel still entails some risk. True, 
vehicles are safer, hostilities are less 
common, and many other threats have 
been reduced. Nevertheless, it has 
become increasingly clear that modern 
travelers, especially long-haul airline 
passengers, face an increased risk of 
thromboembolism as a result of their 
travel [1–5]. The increase is modest, 
perhaps two to four times the baseline 
incidence of about one event in 1,000 
person-years [6]. Age and other risk 
factors, however, greatly elevate the 
baseline risk that some travelers face. 
Given that one to six percent of long-
haul air travelers may be arriving with 
a clot in their veins [4,7,8], most being 
asymptomatic [9], it appears that 
travel-related risk of thrombosis could 
be appreciable for those with high 
baseline risk.
    What forms of travel, and what 
duration, affect the risk? Which 
determinants of thrombosis are 
susceptibility factors for travel-
related risk? What interventions are 
effective? Some of these questions were 
addressed in a study by Cannegieter et 
al., appearing in   PLoS Medicine   [10]. 
The researchers analyzed data collected 
for a population-based case-control 
study of venous thrombosis conducted 
in the Netherlands [11]. Corroborating 
earlier work [1,2,4,5], they found a 
doubling in the eight-week risk of 
venous thromboembolism in travelers 
who journeyed four hours or longer. 
The increase was similar for travel by 
air and for travel by car, bus, or train. 
The authors’ main focus, however, 
was on the interaction of lengthy 
travel with other risk factors. For all 
forms of travel, but especially for air 
travel, they found that factor V Leiden 
thrombophilia, body mass index 
greater than 30, height greater than 1.9 
meters, and use of oral contraceptives 
were strong susceptibility factors. In 
addition, height of less than 1.6 meters 
was also a susceptibility factor for air 
travel.
    Epidemiologists have had a difﬁ  cult 
time studying interactions because this 
objective usually requires substantially 
more data than estimating primary 
effects. When feasible, however, the 
estimation of interaction effects can 
elucidate causal mechanisms and 
even point the way toward targeted 
prevention. Thus, while all long-haul 
travelers are advised to wear loose 
clothing, move about periodically, 
and to exercise in place, tall or heavy 
people, those with factor V Leiden, 
or women taking oral contraceptives 
might additionally consider wearing 
graduated compression stockings or 
taking heparin prophylactically [9].
    Matching in Case-Control Studies
    Cannegieter et al. employed an 
unusual study design, using individually 
matched controls who were the 
partners of cases. Contrary to intuition, 
matching in case-control studies 
does not control confounding, and 
ironically introduces bias toward 
the null when the matching factors 
are related to the study exposure. 
The bias arises because controls are 
intended to provide an estimate 
of the exposure distribution in the 
population from which the cases arise, 
whereas matching on factors related to 
exposure in selecting controls distorts 
the sampling. Consequently, matching 
controls to cases for correlates of 
exposure requires analytic methods 
to remove the selection bias [12]. In 
this study, however, the use of partners 
as controls provided a convenient 
sample of the source population for 
cases, and indirect control for various 
lifestyle factors that might be difﬁ  cult 
to measure. The investigators removed 
the bias introduced by matching 
(manifest, for example, in the tendency 
for partners to travel together) with an 
appropriate analysis.
    Using partners as controls resulted 
in most controls having the opposite 
sex as their matched case. Even so, 
Cannegieter et al. were able to control 
sex differences in the analysis. They 
apparently believed, however, that 
they could not use their matched 
case-control design to study the 
effect of oral contraceptives, because 
only women were users of oral 
contraceptives. Instead, they turned to 
a case-only analysis ([13]; see Glossary) 
just to evaluate the interaction 
between oral contraceptives and travel. 
Unfortunately, the case-only analysis 
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assumes that travel is unrelated to 
oral contraceptive use, a tenuous 
assumption. Furthermore, it requires 
that interaction between travel and 
oral contraceptives be assessed as 
a departure from a multiplicative 
relation, which understates the 
extent of interaction. The assessment 
of biological interaction should be 
based upon measuring excesses above 
additive effects [12,14]. Indeed, if 
the relation is multiplicative, that 
in itself would indicate important 
interaction. Although the greater-
than-multiplicative relation they 
found in this analysis suggests strong 
interaction, the case-only analysis was 
unnecessary. Despite the fact that 
oral-contraceptive use is conﬁ  ned to 
women, the authors could have studied 
its effect using their partner-matched 
case-control data. Think of being male 
as just a reason for a person to be 
unexposed. The matched analysis with 
control of sex would still yield valid 
results. They thus could have examined 
departures from an additive relation 
between oral contraceptives and travel-
related risk, as they did for the other 
interactions that they studied, and 
without the need to assume that travel 
is unrelated to oral-contraceptive use.
  Persistence  and  “Dose-Response” 
Relation of Travel-Related Risk
    Cannegieter et al. also displayed the 
number of cases by week since travel. 
This distribution, however, does not use 
information from controls, and could 
mislead regarding the persistence of 
travel-related risk. It would have been 
more useful to describe the relation 
between relative risk and time since 
travel directly, perhaps with spline 
regression. Similarly, it would have 
been instructive to plot another 
spline-smoothed curve showing the 
relative risk by duration of journey, to 
evaluate the “dose-response” pattern 
and particularly to see if there was an 
obvious time threshold. Future analyses 
of these data should elucidate these 
points. 
    The current ﬁ  ndings are nevertheless 
important both to scientists and long-
haul travelers. The study also raises 
intriguing questions about the risk 
of sitting for several hours without 
moving, an activity—or should we say 
inactivity—considerably more common 
than travel.   
 Glossary
   Case-only  analysis:  A type of case-
control study in which the control series 
is replaced by information obtained from 
the case series.
   Multiplicative  relation:  A relation 
between two risk factors in which the 
relative effects multiply. For example, 
if factor A doubles the risk and factor 
B triples the risk, their relation is 
multiplicative if those with both factors 
have six times the risk relative to those 
without either factor A or factor B.
   Spline  regression:  A regression that 
estimates separate, but connected, 
regression line segments for different 
ranges of the predictor variable. 
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